Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

69.17 +1.77 (+2.63%)

Streaming Delayed Price Updated: 10:10 AM EST, Jan 12, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,014,273
Open	66.74
Bid (Size)	69.12 (100)
Ask (Size)	69.22 (200)
Prev. Close	67.40
Today's Range	65.92 - 70.62
52wk Range	54.11 - 93.25
Shares Outstanding	390,000,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Today 7:30 EST

From DexCom, Inc.

Via Business Wire

DexCom (DXCM) Stock Trades Down, Here Is Why

January 08, 2026

Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and Bernstein lowered their price targets on the stock, citing concerns over the...

Via StockStory

Performance

YTD	+4.0%	+4.0%
1 Month	+3.3%	+3.3%
3 Month	+6.1%	+6.1%
6 Month	-18.9%	-18.9%
1 Year	-13.4%	-13.4%

More News

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

January 07, 2026

From DexCom, Inc.

Via Business Wire

3 Nasdaq 100 Stocks Worth Your Attention

January 04, 2026

Via StockStory

The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature

January 01, 2026

Via PredictStreet

2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky

December 31, 2025

Via StockStory

2 Growth Stocks to Buy For 2026 and Beyond ↗

December 30, 2025

Via The Motley Fool

DexCom Inc (NASDAQ:DXCM) Embodies the Growth at a Reasonable Price (GARP) Strategy ↗

December 30, 2025

Via Chartmill

DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm

December 26, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 26, 2025

From Schall Law

Via GlobeNewswire

The $65 Billion Pulse: How Wearable AI and Telemedicine are Redefining the Future of Healthcare

December 24, 2025

Via MarketMinute

1 Cash-Heavy Stock for Long-Term Investors and 2 We Avoid

December 22, 2025

Via StockStory

DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm

December 22, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit

December 22, 2025

Via TheNewswire.com

DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit

December 22, 2025

Via NewMediaWire

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 22, 2025

From Schall Law

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (NASDAQ: DXCM)

December 22, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

DexCom Inc (NASDAQ:DXCM): A High-Growth Stock Forming a Bullish Technical Setup ↗

December 19, 2025

Via Chartmill

1 Cash-Producing Stock with Impressive Fundamentals and 2 We Ignore

December 18, 2025

Via StockStory

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

December 18, 2025

From Halper Sadeh LLC

Via GlobeNewswire

DXCM DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Dexcom, Inc. (DXCM) Securities Fraud Class Action Lawsuit

December 18, 2025

Via NewMediaWire

DXCM DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Dexcom, Inc. (DXCM) Securities Fraud Class Action Lawsuit

December 18, 2025

Via TheNewswire.com

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 18, 2025

From Schall Law

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (NASDAQ: DXCM)

December 17, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom and CarMax and Encourages Investors to Contact the Firm

December 16, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?

Yes, DexCom, Inc. - Common Stock is publicly traded.

What exchange does DexCom, Inc. - Common Stock trade on?

DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for DexCom, Inc. - Common Stock?

The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market

What is the current price of DexCom, Inc. - Common Stock?

The current price of DexCom, Inc. - Common Stock is 69.17

When was DexCom, Inc. - Common Stock last traded?

The last trade of DexCom, Inc. - Common Stock was at 01/12/26 10:10 AM ET

What is the market capitalization of DexCom, Inc. - Common Stock?

The market capitalization of DexCom, Inc. - Common Stock is 26.98B

How many shares of DexCom, Inc. - Common Stock are outstanding?

DexCom, Inc. - Common Stock has 27B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.